Screener
Aurinia Pharmaceuticals AUPH Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 541,324 | 491,967 |
| Deferred tax assets, net | 178,935 | 176,194 |
| Finance right-of-use lease assets | 65,152 | 73,865 |
| Intangible assets, net | 3,378 | 3,761 |
| Operating right-of-use lease assets | 1,518 | 3,596 |
| Property and equipment, net | 1,862 | 2,111 |
| Other noncurrent assets | 93 | 93 |
| Total assets | $792,262 | $751,587 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's intangibles (net)?
- Aurinia Pharmaceuticals (AUPH) reported intangibles (net) of $3.38M in Q2 2026.
- How has Aurinia Pharmaceuticals's intangibles (net) changed year-over-year?
- Aurinia Pharmaceuticals's intangibles (net) decreased by 16.5% year-over-year, from $4.05M to $3.38M.
- What is the long-term trend for Aurinia Pharmaceuticals's intangibles (net)?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's intangibles (net) has grown at a -16.6% compound annual growth rate (CAGR), from $9.33M to $3.76M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Aurinia Pharmaceuticals's intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude